The role and dilemmas of university hospitals in the drug life cycle
| dc.rights.license | CC-BY-NC-ND | |
| dc.contributor.advisor | Mantel-Teeuwisse, A.K. | |
| dc.contributor.author | Ramlal, Anjani | |
| dc.date.accessioned | 2023-04-01T00:00:58Z | |
| dc.date.available | 2023-04-01T00:00:58Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/43745 | |
| dc.description.sponsorship | Utrecht University | |
| dc.language.iso | EN | |
| dc.subject | This paper describes what roles university hospitals could play in the drug life cycle to keep medicines affordable and what dilemmas they face if they would do so, according to various stakeholders. | |
| dc.title | The role and dilemmas of university hospitals in the drug life cycle | |
| dc.type.content | Master Thesis | |
| dc.rights.accessrights | Open Access | |
| dc.subject.courseuu | Farmacie | |
| dc.thesis.id | 3332 |
